Emcure Pharmaceuticals is trading -1.02% lower at Rs 1,062.80 as compared to its last closing price. Emcure Pharmaceuticals has been trading in the price range of 1,135.55 & 1,044.35. There are 3 analysts who have initiated coverage on Emcure Pharmaceuticals. There are 2 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 153.72 Crores in its last quarter.The Mutual Fund holding in Emcure Pharmaceuticals was at 3.10% in 31 Dec 2024. The MF holding has decreased from the last quarter. The FII holding in Emcure Pharmaceuticals was at 3.05% in 31 Dec 2024. The FII holding has increased from the last quarter.
Updated on Feb 13, 2025, 08:12 PM UTC
|
|
|
|
Meeting Date | Purpose |
---|---|
2025-02-06 | Quarterly Results |
2024-11-07 | Quarterly Results |
2024-08-13 | Quarterly Results |
Emcure Pharmaceuticals is trading at 1062.80 as on Thu Feb 13 2025 10:14:27. This is -1.02% lower as compared to its previous closing price of 1073.75.
The market capitalization of Emcure Pharmaceuticals is 20142.50 Cr as on Thu Feb 13 2025 10:14:27.
The average broker rating on Emcure Pharmaceuticals is Strong Buy. The breakup of analyst rating is given below -
The 52 wk high for Emcure Pharmaceuticals is 1577.50 whereas the 52 wk low is 1063.00
Emcure Pharmaceuticals can be analyzed on the following key metrics -
Emcure Pharmaceuticals reported a net profit of 498.18 Cr in 2024.
The Mutual Fund Shareholding was 3.10% at the end of 31 Dec 2024.